プレスリリース
画期的な研究を支援する新製品、お客様との戦略的パートナーシップ、私たちのミッションの一つである慈善活動のパートナーシップなど、常にさまざまな事業に取り組んでいます。以下に直近のプレスリリースを示します。日付やトピックで絞り込みができます。
お問い合わせ
報道関係のお問い合わせはこちら：
Rachel Bloom-Baglin
Phone: +1 978 436 1725
Apr 17, 2024
MilliporeSigma Inspires Students to Explore STEM Careers with 2024 Curiosity Cube TourMilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, officially kicked off its global 2024 Curiosity Cube tour today in Darmstadt, Germany.
Apr 16, 2024
Merck Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety TestingMerck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its kind.
Feb 28, 2024
Feb 13, 2024
Press Release Test AEM3-605Teaser text.
Nov 25, 2022
AEM2-823-PR - - Merck Announces Closing of Exelead Acquisition and Plans to Invest More Than € 500 Million in Technology Scale-UpMerck, the U.S. and Canada Life Science business sector of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing conditions, for approximately USD 780 million in cash. The business combination is expected to enable the Life Science business to provide its customers with comprehensive end-to-end contract development and manufacturing organization (CDMO) services across the mRNA value chain. The Life Science business plans to further invest over € 500 million to scale up Exelead’s technology over the next ten years.
Nov 01, 2022
続きを確認するには、ログインするか、新規登録が必要です。
アカウントをお持ちではありませんか？